Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JS']JSGO-JS']JSOG joint study

被引:4
作者
Seino, Manabu [8 ,9 ]
Nagase, Satoru
Ohta, Tsuyoshi [2 ]
Yamagami, Wataru [1 ]
Ebina, Yasuhiko [3 ]
Kobayashi, Yoichi [4 ]
Tabata, Tsutomu [4 ]
Kaneuchi, Masanori [5 ]
Enomoto, Takayuki [6 ]
Mikami, Mikio [7 ]
机构
[1] Yamagata Univ, Dept Obstet & Gynecol, Fac Med, Yamagata, Japan
[2] Keio Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan
[3] Hokkaido Univ, Fac Hlth Sci, Div Comprehens Dev Nursing, Sapporo, Japan
[4] Kyorin Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan
[5] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan
[6] Otaru Gen Hosp, Dept Obstet & Gynecol, Otaru, Japan
[7] Niigata Univ Grad, Dept Obstet & Gynecol, Sch Med, Niigata, Japan
[8] Tokai Univ, Dept Obstet & Gynecol, Sch Med, Isehara, Japan
[9] Yamagata Univ, Dept Obstet & Gynecol, Sch Med, 2-2-2 Iidanishi, Yamagata 9909585, Japan
关键词
Uterine Cervical Neoplasms; Small Cell Neuroendocrine Tumor; Pelvic Lymph-Node Metastasis; Adjuvant Therapy; UTERINE CERVIX; PROGNOSTIC-FACTORS; CARCINOMA; TUMORS; MULTICENTER; MANAGEMENT; DIAGNOSIS;
D O I
10.3802/jgo.2023.34.e4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to review the clinicopathological characteristics of small cell neuroendocrine cervical cancer (SCNEC) and to identify the optimal treatment.Methods: The Japanese Society of Gynecologic Oncology conducted a retrospective cohort study of SCNECs enrolled in the Gynecological Tumor Registry of the Japan Society of Obstetrics and Gynecology between 2004 and 2015. All cases were modified and unified by International Federation of Gynecology and Obstetrics 2008 (Union for International Cancer Control 7th edition).Results: There were 822 registered patients diagnosed with SCNEC from 2004 to 2015 which comprised 1.1% (822/73,698) of all uterine cervical cancer cases. Rates of lymph-node and distant metastasis were significantly higher in T1b2 (38.9% and 13.7%, respectively) than T1b1 (14.2% and 4.4%, respectively) (p < 0.01). In IB2 and T1bN1M0 SCNEC, the 5-year survival rate with surgery followed by chemotherapy was significantly higher than that with surgery followed by radiation therapy/concurrent chemoradiation therapy (p < 0.01).Conclusion: SNCEC tumors > 4 cm in size had greater rates of lymph-node and distant metastasis when compared with tumors <= 4 cm. Adjuvant chemotherapy, rather than radiotherapy, may improve prognosis after surgery in T1bN1M0 SCNEC.
引用
收藏
页数:1
相关论文
共 25 条
[1]  
ABELER VM, 1994, CANCER, V73, P672, DOI 10.1002/1097-0142(19940201)73:3<672::AID-CNCR2820730328>3.0.CO
[2]  
2-R
[3]   Challenges in the diagnosis and management of cervical neuroendocrine carcinoma [J].
Burzawa, Jennifer ;
Gonzales, Naomi ;
Frumovitz, Michael .
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (07) :805-810
[4]  
Cancer Information Service National Cancer Center, 2022, CERVIX
[5]   Prognostic factors in neuroendocrine small cell cervical carcinoma - A multivariate analysis [J].
Chan, JK ;
Loizzi, V ;
Burger, RA ;
Rutgers, J ;
Monk, BJ .
CANCER, 2003, 97 (03) :568-574
[6]   Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03) [J].
Cho, Won Kyung ;
Park, Won ;
Kim, Young Seok ;
Kang, Hyun-Cheol ;
Kim, Jin Hee ;
Kim, Kyung Su ;
Choi, Kyu Hye ;
Chang, Sei Kyung ;
Ahn, Ki Jung ;
Lee, Seok Ho ;
Kim, Sunghyun ;
Kim, Juree ;
Eom, Keun-Yong ;
Lee, Jeongshim ;
Lee, Jong Hoon ;
Choi, Jin Hwa .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 258 :396-400
[7]   Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients [J].
Cohen, Joshua G. ;
Kapp, Daniel S. ;
Shin, Jacob Y. ;
Urban, Renata ;
Sherman, Alexander E. ;
Chen, Lee-may ;
Osann, Kathryn ;
Chan, John K. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (04) :347.e1-347.e6
[8]   Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document [J].
Gardner, Ginger J. ;
Reidy-Lagunes, Diane ;
Gehrig, Paola A. .
GYNECOLOGIC ONCOLOGY, 2011, 122 (01) :190-198
[9]   Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis [J].
Gibbs, Jennifer ;
Mei, Shirley ;
Economos, Katherine ;
Lee, Yi-Chun ;
Kanis, Margaux J. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (01) :53.e1-53.e6
[10]   Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study [J].
Ishikawa, Mitsuya ;
Kasamatsu, Takahiro ;
Tsuda, Hitoshi ;
Fukunaga, Masaharu ;
Sakamoto, Atsuhiko ;
Kaku, Tsunehisa ;
Nakanishi, Toru ;
Hasumi, Yoko ;
Iwata, Takashi ;
Baba, Tsukasa ;
Nogawa, Takayoshi ;
Kudaka, Wataru ;
Kaneda, Hiroshi ;
Ono, Shigemitsu ;
Saito, Fumitaka ;
Taniguchi, Yoshimi ;
Okada, Satoshi ;
Mizuno, Mika ;
Onda, Takashi ;
Yaegashi, Nobuo .
GYNECOLOGIC ONCOLOGY, 2018, 148 (01) :139-146